Alan Crowther
General Manager, Global Pricing, Access and Digital Solutions
Expertise:
Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection and analysis, and the use of advanced algorithms to support commercial decisions, including pricing.
Alan has shared his expertise and insight and has spoken extensively at a number of pharmaceutical conferences on drug and device pricing. He was previously the CEO of Alliance Life Sciences and prior to that held positions as vice president in life sciences at Adjoined/Capgemini and as managing officer in Andersen Consulting, where he led a number of large technology projects.
Alan is a graduate of Princeton University.
Articles by Alan Crowther
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
The EU Health Technology Assessment Regulation (EU HTAR) and Joint Clinical Assessment (JCA) aim to harmonize clinical evaluations across Europe while preserving national HTA decisions. To navigate this complexity, early and strategic PICO (Population, Intervention, Comparator, Outcome) planning is essential for effective evidence generation strategies. This study, presented at ISPOR Europe 2025, demonstrates how NAVLIN […]
Key Trends in Global Product Launch
The pharmaceutical industry continues to face a multitude of changes that have the potential to directly impact launch strategy. From more recent tangible trends like a rise in cost-containment policies, to ongoing net price transparency forces and a focus on health equity, the potential to make mistakes during launch is growing. Reasons for traditional launch […]